Aclaris Therapeutics, Inc. (ACRS) Discusses at 2025 R&D Day (Transcript)

Core Points - Aclaris is hosting its 2025 R&D Day in New York, indicating a focus on research and development initiatives for the upcoming year [1] - The event is attended by both in-person participants and those joining via webcast, highlighting the company's commitment to engaging with stakeholders [1] Summary by Sections - Company Overview - Aclaris is led by William Roberts, who serves as the Senior VP of Corporate Communications & Investor Relations [1] - Event Details - The 2025 R&D Day is positioned as a significant event for the company, suggesting that important updates and future plans will be discussed [1] - The presentation includes forward-looking statements, which are essential for understanding the company's strategic direction and potential risks [2]